FR2531857B1 - Composition injectable pour prolonger la stabilite et la retention de particules enrobees, injectees dans le flux sanguin d'animaux et d'etres humains - Google Patents

Composition injectable pour prolonger la stabilite et la retention de particules enrobees, injectees dans le flux sanguin d'animaux et d'etres humains

Info

Publication number
FR2531857B1
FR2531857B1 FR8312439A FR8312439A FR2531857B1 FR 2531857 B1 FR2531857 B1 FR 2531857B1 FR 8312439 A FR8312439 A FR 8312439A FR 8312439 A FR8312439 A FR 8312439A FR 2531857 B1 FR2531857 B1 FR 2531857B1
Authority
FR
France
Prior art keywords
prolonging
animals
retention
stability
blood flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8312439A
Other languages
English (en)
Other versions
FR2531857A1 (fr
Inventor
Henry A Sloviter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of FR2531857A1 publication Critical patent/FR2531857A1/fr
Application granted granted Critical
Publication of FR2531857B1 publication Critical patent/FR2531857B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026Blood substitute; Oxygen transporting formulations; Plasma extender

Landscapes

  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8312439A 1982-07-27 1983-07-27 Composition injectable pour prolonger la stabilite et la retention de particules enrobees, injectees dans le flux sanguin d'animaux et d'etres humains Expired FR2531857B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/402,449 US4397870A (en) 1982-07-27 1982-07-27 Process for prolonging retention of emulsion particles in the bloodstream

Publications (2)

Publication Number Publication Date
FR2531857A1 FR2531857A1 (fr) 1984-02-24
FR2531857B1 true FR2531857B1 (fr) 1986-04-11

Family

ID=23591925

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8312439A Expired FR2531857B1 (fr) 1982-07-27 1983-07-27 Composition injectable pour prolonger la stabilite et la retention de particules enrobees, injectees dans le flux sanguin d'animaux et d'etres humains

Country Status (6)

Country Link
US (1) US4397870A (fr)
CA (1) CA1201655A (fr)
DE (1) DE3326900A1 (fr)
FR (1) FR2531857B1 (fr)
GB (1) GB2124079B (fr)
SE (1) SE8304144L (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5924132B2 (ja) * 1980-12-02 1984-06-07 株式会社 林原生物化学研究所 栄養補給用乳剤の製法
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
GB8407557D0 (en) * 1984-03-23 1984-05-02 Hayward J A Polymeric lipsomes
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4927623A (en) * 1986-01-14 1990-05-22 Alliance Pharmaceutical Corp. Dissolution of gas in a fluorocarbon liquid
US4865836A (en) * 1986-01-14 1989-09-12 Fluoromed Pharmaceutical, Inc. Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
US5080885A (en) * 1986-01-14 1992-01-14 Alliance Pharmaceutical Corp. Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
US4987154A (en) * 1986-01-14 1991-01-22 Alliance Pharmaceutical Corp. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
US5077036A (en) * 1986-01-14 1991-12-31 Alliance Pharmaceutical Corp. Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
DE3700911C2 (de) * 1986-01-17 2001-05-17 West Pharm Serv Drug Res Ltd System zur Zuführung eines Arzneimittels oder eines Diagnostikums
US5514720A (en) * 1986-07-09 1996-05-07 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
US5684050A (en) * 1986-01-24 1997-11-04 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
EP0257758B1 (fr) * 1986-08-07 1993-03-10 Minnesota Mining And Manufacturing Company Emulsions fluorochimiques biologiquement actives, stables
US4895876A (en) * 1987-03-20 1990-01-23 Air Products And Chemicals, Inc. Concentrated stable fluorochemical aqueous emulsions containing triglycerides
US4866096A (en) * 1987-03-20 1989-09-12 Air Products And Chemicals, Inc. Stable fluorochemical aqueous emulsions
US4956390A (en) * 1987-08-25 1990-09-11 Air Products And Chemicals, Inc. Gas transport employing perfluorobutyldecalin
EP0318081B1 (fr) * 1987-11-27 1991-07-24 Akzo N.V. Stabilisation d'anticorps
US5061484A (en) * 1988-03-11 1991-10-29 Alpha Therapeutic Corporation Perfluorochemical emulsion with stabilized vesicles
US5171755A (en) * 1988-04-29 1992-12-15 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
EP0480925B1 (fr) * 1989-07-05 1997-09-24 Alliance Pharmaceutical Corporation Emulsions de fluorocarbones contenant des emulsifiants a base de phospholipides satures
US5146014A (en) * 1991-07-02 1992-09-08 Air Products And Chemicals, Inc. Perfluoroethyldimethyl cyclohexane
US5403575A (en) * 1991-12-12 1995-04-04 Hemagen/Pfc Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
US5350359A (en) * 1992-07-16 1994-09-27 Temple University Of The Commonwealth System Of Higher Education Control, treatment and/or diagnosis of physiological conditions with degassed perfluorocarbon liquid
DE4308312A1 (de) * 1993-03-16 1994-09-22 Fresenius Ag Kardioplegische Emulsion
US6679859B1 (en) 1997-10-24 2004-01-20 Alliance Pharmaceutical Corp. Amelioration of ischemic damage using synthetic oxygen carriers
US8192845B2 (en) * 2005-11-04 2012-06-05 Cargill, Incorported Lecithin-containing starch compositions, preparation thereof and paper products having oil and grease resistance, and/or release properties
US7931778B2 (en) 2005-11-04 2011-04-26 Cargill, Incorporated Lecithin-starches compositions, preparation thereof and paper products having oil and grease resistance, and/or release properties

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3958014A (en) * 1970-09-05 1976-05-18 The Green Cross Corporation Process for preparing injection-purpose fluorocarbon emulsion capable of carrying oxygen
CH604490A5 (fr) * 1970-09-05 1978-09-15 Green Cross Corp
JPS5331209B2 (fr) * 1973-10-05 1978-09-01
FR2249657B1 (fr) * 1973-11-07 1977-04-15 Ugine Kuhlmann
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
GB1578776A (en) * 1976-06-10 1980-11-12 Univ Illinois Hemoglobin liposome and method of making the same
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
US4186253A (en) * 1978-10-10 1980-01-29 The Green Cross Corporation Perfusate for preserving organ to be transplanted and preserving method
US4252827A (en) * 1979-05-23 1981-02-24 The Green Cross Corporation Oxygen-transferable fluorocarbon emulsion
AR220263A1 (es) * 1980-02-19 1980-10-15 Bago Lab Sa Procedimiento para obtener una preparacion inyectable de sulfonamida potenciada de baja irritabilidad

Also Published As

Publication number Publication date
CA1201655A (fr) 1986-03-11
GB8318541D0 (en) 1983-08-10
GB2124079A (en) 1984-02-15
FR2531857A1 (fr) 1984-02-24
GB2124079B (en) 1987-02-04
US4397870A (en) 1983-08-09
SE8304144D0 (sv) 1983-07-26
DE3326900A1 (de) 1984-02-16
SE8304144L (sv) 1984-01-28

Similar Documents

Publication Publication Date Title
FR2531857B1 (fr) Composition injectable pour prolonger la stabilite et la retention de particules enrobees, injectees dans le flux sanguin d'animaux et d'etres humains
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
DE3685800D1 (de) Fluidumfilter und dessen fluidumdichte befestigung.
ES512259A0 (es) "procedimiento para la preparacion de nuevos derivados piperidinicos piperacinicos y homopiperacinicos".
IT8967528A0 (it) Composti carbossiammidici procedi menti per la preparazione dei mede simi e composizione farmaceutica contenente i medesimi
BE888082A (fr) Compositions cosmetiques ou pharmaceutiques sous forme d'emulsions stables du type huile-dans-l'eau
DE3670076D1 (de) Acrylatverbindung und diese enthaltende zusammensetzung.
GB2090529A (en) Thrombosis-prophylactic and curing agent
IT8324035A0 (it) Cefem composti ad attivita'farmaceutica e procedimenti per laloro preparazione.
FR2530468B1 (fr) Composition analgesique et anti-inflammatoire contenant de l'ibuprofen
DE3678643D1 (de) Partikel mit konstanter wirkstofffreisetzung.
FR2567510B1 (fr) Composes d'aminophenol et compositions pharmaceutiques les contenant
FR2587989B1 (fr) Compositions particulaires d'oxalates de metaux ferromagnetiques, sous forme de particules aciculaires submicroniques, leur preparation et leur application
DE3678641D1 (de) Partikel mit konstanter wirkstofffreisetzung.
FR2595730B1 (fr) Compositions stables au stockage d'absorbants u.v.
AR231144A1 (es) Procedimiento para la preparacion de 5'-desoxi-5'-metilticadenosina con actividad antiinflamatoria y analgesica
IT8249207A0 (it) Procedimento per l'arricchimento disolfuri metallici e composizione diraccolta impiegata
FR2538706B1 (fr) Ensemble de preparation et de delivrance d'un solute
FR2620163B1 (fr) Blindage notamment pour coffre-fort et coffre-fort s'y rapportant
IT8323601A0 (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete.
MA19965A1 (fr) 3',5'-diarabinosides, leur preparation et leur application en therapeutique
IT1168163B (it) Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative
FR2505825B1 (fr) Derives d'isoprenylamine et leur utilisation dans des compositions pharmaceutiques
FR2523580B1 (fr) Pyrimidine-dicarbamates et leur utilisation dans la preparation d'oxadiazolopyrimidines connues en tant que medicaments hypotenseurs
BE895664A (fr) Esters d'acides phenoxyphenoxypropioniques leur preparation et leur utilisation

Legal Events

Date Code Title Description
ST Notification of lapse